# Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors

> **NCT03407716** · EARLY_PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 2 (actual)

## Conditions studied

- Cancer Survivor
- Stage I Breast Cancer AJCC v7
- Stage I Colon Cancer AJCC v6 and v7
- Stage IA Breast Cancer AJCC v7
- Stage IB Breast Cancer AJCC v7
- Stage II Breast Cancer AJCC v6 and v7
- Stage II Colon Cancer AJCC v7
- Stage IIA Breast Cancer AJCC v6 and v7
- Stage IIA Colon Cancer AJCC v7
- Stage IIB Breast Cancer AJCC v6 and v7
- Stage IIB Colon Cancer AJCC v7
- Stage IIC Colon Cancer AJCC v7
- Stage III Breast Cancer AJCC v7
- Stage III Colon Cancer AJCC v7
- Stage IIIA Breast Cancer AJCC v7
- Stage IIIA Colon Cancer AJCC v7
- Stage IIIB Breast Cancer AJCC v7
- Stage IIIB Colon Cancer AJCC v7
- Stage IIIC Breast Cancer AJCC v7
- Stage IIIC Colon Cancer AJCC v7

## Interventions

- **DRUG:** American Ginseng
- **OTHER:** Laboratory Biomarker Analysis
- **OTHER:** Placebo
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT03407716
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-01
- **Primary completion:** 2020-05-13
- **Final completion:** 2021-02-22
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2023-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03407716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03407716, "Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03407716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*